These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37854684)

  • 1. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
    Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
    Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases.
    Uder L; Nachbar M; Butzer S; Boldt J; Baumeister S; Bitzer M; Königsrainer A; Seufferlein T; Hoffmann R; Gatidis S; Nikolaou K; Zips D; Thorwarth D; Gani C; Boeke S
    Front Oncol; 2022; 12():1095633. PubMed ID: 36727060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy.
    Teunissen FR; Willigenburg T; Tree AC; Hall WA; Choi SL; Choudhury A; Christodouleas JP; de Boer JCJ; de Groot-van Breugel EN; Kerkmeijer LGW; Pos FJ; Schytte T; Vesprini D; Verkooijen HM; van der Voort van Zyp JRN
    Pract Radiat Oncol; 2023; 13(3):e261-e269. PubMed ID: 36462619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerability.
    Nicosia L; Mazzola R; Rigo M; Giaj-Levra N; Pastorello E; Ricchetti F; Vitale C; Figlia V; Cuccia F; Ruggieri R; Alongi F
    Radiol Med; 2023 May; 128(5):612-618. PubMed ID: 37055672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
    van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
    Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study.
    Sritharan K; Daamen L; Pathmanathan A; Schytte T; Pos F; Choudhury A; van der Voort van Zyp JRN; Kerkmeijer LGW; Hall W; Hall E; Verkooijen HM; Herbert T; Hafeez S; Mitchell A; Tree AC
    Clin Transl Radiat Oncol; 2024 May; 46():100742. PubMed ID: 38440792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
    de Mol van Otterloo SR; Christodouleas JP; Blezer ELA; Akhiat H; Brown K; Choudhury A; Eggert D; Erickson BA; Faivre-Finn C; Fuller CD; Goldwein J; Hafeez S; Hall E; Harrington KJ; van der Heide UA; Huddart RA; Intven MPW; Kirby AM; Lalondrelle S; McCann C; Minsky BD; Mook S; Nowee ME; Oelfke U; Orrling K; Sahgal A; Sarmiento JG; Schultz CJ; Tersteeg RJHA; Tijssen RHN; Tree AC; van Triest B; Hall WA; Verkooijen HM
    Front Oncol; 2020; 10():1328. PubMed ID: 33014774
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
    Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
    Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
    Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
    Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
    Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
    Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
    Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer.
    Song Y; Zhang Y; Wang H; Zhao M; Guan F; Li Z; Yue J
    Front Oncol; 2023; 13():1159197. PubMed ID: 37746250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
    Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
    Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.
    Daamen LA; de Mol van Otterloo SR; van Goor IWJM; Eijkelenkamp H; Erickson BA; Hall WA; Heerkens HD; Meijer GJ; Molenaar IQ; van Santvoort HC; Verkooijen HM; Intven MPW
    Acta Oncol; 2022 Jan; 61(1):111-115. PubMed ID: 34879792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC.
    Almog G; Pfeffer RM; Zalmanov S; Grinberg V; Lipsky Y; Chernomordikov E; Levin D; Apter S; Arsenault O; Epstein D; Tamimi Q; Hod K; Limon D; Golan T; Ben-Aharon I; Lawrence YR; Ben-David MA
    Front Oncol; 2023; 13():1289919. PubMed ID: 38074644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.
    Sandoval ML; Youssef I; Latifi K; Grass GD; Torres-Roca J; Rosenberg S; Yamoah K; Johnstone PA
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.